Prevalence of Adenomyosis in Patients Hysterectomized for Other Benign Uterine Pathology in the General Hospital of Cancun in the Year 2021 - 2023

article OA: green CC0
AI-generated deep summary by claude@2026-07, 2026-07-03 · read from full text

The paper investigated the prevalence of adenomyosis among patients who underwent hysterectomy for other benign uterine pathologies at Hospital General de Cancún between 2021 and 2023. Using post-hysterectomy histopathological analysis, it evaluated how often adenomyosis was detected in this surgical population, motivated by the fact that diagnosis is difficult and often depends on tissue examination. A stated limitation is that diagnosis is contingent on histopathology and imaging accuracy remains limited, which frames the study’s reliance on surgical specimens rather than preoperative tools. This paper is centrally about adenomyosis prevalence in a hysterectomy cohort, directly relating to adenomyosis as the study’s primary outcome.

Read from the paper's body, not the abstract. Not a substitute for reading the paper. No clinical advice. How this works

Abstract

Introduction: Adenomyosis is a benign pathology of the uterus characterized by the infiltration of endometrial tissue into the myometrium, resulting in symptoms such as dysmenorrhea, abnormal uterine bleeding and chronic pelvic pain. Its diagnosis remains a challenge due to the reliance on post-hysterectomy histopathological analysis and the limited accuracy of imaging methods. This study aims to determine the prevalence of adenomyosis in patients undergoing hysterectomy for benign pathologies of the uterus at the General Hospital of Cancun during the period 2021-2023.
Full text 1,340 characters · extracted from oa-doi-fallback · click to expand
Prevalence of Adenomyosis in Patients Hysterectomized for Other Benign Uterine Pathology in the General Hospital of Cancun in the Year 2021 - 2023 Authors/Creators - 1. Gynecology and Obstetrics Resident. Hospital General de Cancún "Dr. Jesús Kumate Rodríguez", Secretaría de Salud. Facultad de Medicina de la Universidad Autónoma de Yucatán. - 2. Gynecologist and Obstetrician. Hospital General de Cancún "Dr. Jesús Kumate Rodríguez", Secretaría de Salud. - 3. MD Universidad Marista de Mérida. Master's Degree in Translational Medicine, Complutense University of Madrid. Description Introduction: Adenomyosis is a benign pathology of the uterus characterized by the infiltration of endometrial tissue into the myometrium, resulting in symptoms such as dysmenorrhea, abnormal uterine bleeding and chronic pelvic pain. Its diagnosis remains a challenge due to the reliance on post-hysterectomy histopathological analysis and the limited accuracy of imaging methods. This study aims to determine the prevalence of adenomyosis in patients undergoing hysterectomy for benign pathologies of the uterus at the General Hospital of Cancun during the period 2021-2023. Files 2190-Article Text-5730-1-10-20250311.pdf Files (296.8 kB) | Name | Size | Download all | |---|---|---| | md5:0e2148eaf60a9b1ea81c5e404fcd663f | 296.8 kB | Preview Download |

Text is read by the "Ask this paper" AI Q&A widget below. Extraction quality varies by source — PMC NXML preserves structure cleanly, OA-HTML may include some navigation residue, and OA-PDF can have broken hyphenation. The publisher copy (via DOI) is the canonical version.

My notes (saved in your browser only)

Ask this paper AI returns verbatim quotes from the full text · source: oa-doi-fallback

Answers must be backed by verbatim quotes from this paper's full text. Hallucinated quotes are dropped automatically; if no verbatim passage answers the question, we say so. How this works

Condition tags

adenomyosischronic_pelvic_paindysmenorrhea

Citation neighborhood (no data yet)

We don't have any in-corpus citations linked to this paper yet. This is a recent paper (2025) — citers typically take a year or two to land, and the OpenAlex reference graph may still be filling in.

Source provenance

openalex
last seen: 2026-05-10T10:53:19.652828+00:00
License: CC0 · commercial use OK